摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-(1-phenylethyl)phenyl)methanol | 117455-21-7

中文名称
——
中文别名
——
英文名称
(4-(1-phenylethyl)phenyl)methanol
英文别名
4-hydroxymethyl-α-methyldiphenylmethane;[4-(1-Phenylethyl)phenyl]methanol
(4-(1-phenylethyl)phenyl)methanol化学式
CAS
117455-21-7
化学式
C15H16O
mdl
——
分子量
212.291
InChiKey
AUDJKVPCROOKIH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    4-溴苄醇乙基溴苯新铜试剂 、 nickel(II) perchlorate hexahydrate 、 四丁基溴化铵 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 反应 10.0h, 以71%的产率得到(4-(1-phenylethyl)phenyl)methanol
    参考文献:
    名称:
    镍催化的烷基卤与芳基卤的电化学还原中继交叉偶联。
    摘要:
    在未分开的电池中已经开发出芳基卤化物和烷基卤化物之间的高度区域选择性的镍催化的电化学还原中继交叉偶联。在这些温和的反应条件下可以耐受各种官能团,这为合成1,1-二芳基烷烃提供了另一种方法。
    DOI:
    10.1002/anie.201912753
点击查看最新优质反应信息

文献信息

  • TAILORED CONTROL OF SURFACE PROPERTIES BY CHEMICAL MODIFICATION
    申请人:Moloney Mark
    公开号:US20100068783A1
    公开(公告)日:2010-03-18
    A process for producing a substrate having an adhesive surface, which process comprises: (a) contacting the substrate with a carbene precursor, which carbene precursor is a compound of the following formula (1): whose substituent groups are SP defined herein, provided that when R is aryl or heteroaryl, said aryl or heteroaryl may be substituted by one, two, three, four or five groups, which groups are independently selected from various groups including -L B -W B ; and (b) either: (i) when W A or W B comprises an adhesive functional group, generating a carbene reactive intermediate from the carbene precursor so that it reacts with the substrate to functionalise the surface, thereby yielding said substrate having an adhesive surface; or (ii) when W A or W B comprises a group which is a precursor of an adhesive functional group, generating a carbene reactive intermediate from the carbene precursor so that it reacts with the substrate to functionalise the surface, and (c) converting said group which is a precursor into an adhesive functional group thereby yielding said substrate having an adhesive surface. The invention further relates to carbene precursor compounds for use in the process, substrates produced by the process and to processes for preparing certain precursor compounds.
    一种生产具有粘附表面的基板的方法,该方法包括:(a)将基板与卡宾前体接触,所述卡宾前体是以下式(1)的化合物:其取代基团为本文所定义的SP,但当R为芳基或杂环芳基时,所述芳基或杂环芳基可以被一个、两个、三个、四个或五个独立选择的各种取代基团之一取代,这些取代基团包括-LB-WB;和(b):要么:(i)当WA或WB包含粘附功能基团时,从卡宾前体生成卡宾活性中间体,使其与基板反应以功能化表面,从而产生具有粘附表面的基板;或(ii)当WA或WB包含是粘附功能基团的前体时,从卡宾前体生成卡宾活性中间体,使其与基板反应以功能化表面,并且(c)将所述作为前体的基团转化为粘附功能基团,从而产生具有粘附表面的基板。该发明还涉及用于该方法的卡宾前体化合物,以及通过该方法生产的基板和用于制备某些前体化合物的方法。
  • Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0268878A2
    公开(公告)日:1988-06-01
    Disclosed herein are salicylic acid copolymers having a weight average molecular weight of 500 10,000 and obtained (a) by condensing salicylic acid (i) with a benzyl alcohol (ii) and/or benzyl ether (iii) or a benzyl halide (iv) in the presence of an acid catalyst or (b) by reacting a co-condensation resin of (i) and (ii) and/or (iii) with (iv) or (c) by reacting a co-condensation resin of (i) and (ii) and/or (iii) or (iv) with a styrene derivative in the presence of an acid catalyst; multivalent metal salts of the salicylic acid copolymers; color-developing agents comprising the multivalent metal salts; and color-developing sheets suited for pressure-sensitive copying paper and comprising the color-developing agents. Their production processes are also disclosed.
    本文公开了水杨酸共聚物,其重量平均分子量为 500 10、000 的水杨酸共聚物;(a)在酸催化剂存在下,将水杨酸(i)与苄醇(ii)和/或苄醚(iii)或苄基卤化物(iv)缩合而得,或(b)将(i)和(ii)和/或(iii)的共缩合树脂与(iv)反应而得,或(c)在酸催化剂存在下,将(i)和(ii)和/或(iii)或(iv)的共缩合树脂与苯乙烯衍生物反应而得;水杨酸共聚物的多价金属盐;由多价金属盐组成的显色剂;以及由显色剂组成的适用于压敏复印纸的显色薄片。此外,还公开了它们的生产工艺。
  • Color-developing compositions and their use
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0523697A1
    公开(公告)日:1993-01-20
    A color-developing composition comprises a multivalent-metal-modified salicylic acid resin (Resin A) and a polycondensation resin (resin B) at a weight ratio of 90-30 to 10-70. Resin A is composed of 5-35 mole% of a structural unit (I) and 65-95 mole% of at least one structural unit (II) or 65-95 mole% of a coupled structural unit of at least one unit (II) and at least one unit (III) and has a weight-average molecular weight of 350-5,000. Resin B is composed of the unit (II) and/or the unit (III) and has a weight-average molecular weight of 350-5,000. wherein Z represents M/m, M being a metal ion of m valence and m being an integer; R₁ and R₂ represent H or a C₁₋₁₂ alkyl, aralkyl, aryl or cycloalkyl group; R₃ and R₆ represent H or a C₁₋₄ alkyl group; and R₄ and R₅ represent H or CH₃.
    一种显色组合物包括一种多价金属改性水杨酸树脂(树脂 A)和一种缩聚树脂(树脂 B),两者的重量比为 90-30 比 10-70。树脂 A 由 5-35 摩尔%的结构单元(I)和 65-95 摩尔%的至少一个结构单元(II)或 65-95 摩尔%的至少一个单元(II)和至少一个单元(III)的耦合结构单元组成,其重量平均分子量为 350-5000。树脂 B 由单元(II)和/或单元(III)组成,重量平均分子量为 350-5000。 其中 Z 代表 M/m,M 为 m 价金属离子,m 为整数;R₁ 和 R₂ 代表 H 或 C₁₋₁₂ 烷基、芳基、芳烷基或环烷基;R₃ 和 R₆ 代表 H 或 C₁₋₄ 烷基;以及 R₄ 和 R₅ 代表 H 或 CH₃。
  • Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP0594149A2
    公开(公告)日:1994-04-27
    This invention provides a condensed pyrazole derivative of the Formula (1) : (where A denotes CH or N, RO and R3 denote same or different, a hydrogen atom or a lower alkyl group, R1 and R2 denote same or different, a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group or a halogen atom, m denotes 1 or 2, and n denotes 1, 2 or 3, provided that, when n is 2, two R2 may be connected to each other to form a lower alkylenedioxy group), or its pharmaceutically acceptable salt. This derivative or its salt is excellent in the effect of inhibiting the expression of action of androgen, thereby being excellent in therapeutical effect of benign prostatic hypertrophy, prostatic carcinoma, etc., and has a long lasting of efficacy and high oral absorption.
    本发明提供了一种式(1)的缩合吡唑衍生物: (其中A表示CH或N,RO和R3表示相同或不同的氢原子或低级烷基,R1和R2表示相同或不同的氢原子、低级烷基、低级烷氧基、低级烷硫基、硝基或卤素原子,m表示1或2,n表示1、2或3,但当n为2时,两个R2可相互连接形成低级烷二氧基),或其药学上可接受的盐。该衍生物或其盐具有良好的抑制雄激素作用表达的效果,从而对良性前列腺肥大、前列腺癌等具有良好的治疗效果,且药效持久,口服吸收率高。
  • Han, Chong; Buchwald, Stephen L., Journal of the American Chemical Society, 2009, vol. 131, p. 7532 - 7533
    作者:Han, Chong、Buchwald, Stephen L.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐